BCG VACCINE AJV

This brand name is authorized in Estonia, Finland, France, New Zealand, Poland, UK.

Active ingredients

The drug BCG VACCINE AJV contains one active pharmaceutical ingredient (API):

1	BCG vaccine UNII 2XQ558L16Z - BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
	BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known.
	Read more about BCG vaccine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BCG VACCINE Powder and solvent for suspension for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07AN01	Tuberculosis, live attenuated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AN Tuberculosis vaccines
Discover more medicines within J07AN01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1042186
FI	Lääkealan turvallisuus- ja kehittämiskeskus	436176
FR	Base de données publique des médicaments	61077869
GB	Medicines & Healthcare Products Regulatory Agency	372402
NZ	Medicines and Medical Devices Safety Authority	7734
PL	Rejestru Produktów Leczniczych	100203763